Invacare Company Profile (NYSE:IVC)

About Invacare (NYSE:IVC)

Invacare logoInvacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company's geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:IVC
  • CUSIP: 46120310
  • Web:
  • Market Cap: $470.44 million
  • Outstanding Shares: 32,783,000
Average Prices:
  • 50 Day Moving Avg: $13.49
  • 200 Day Moving Avg: $12.41
  • 52 Week Range: $8.00 - $16.65
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -84.41
  • P/E Growth: -1.22
Sales & Book Value:
  • Annual Revenue: $1.02 billion
  • Price / Sales: 0.46
  • Book Value: $12.43 per share
  • Price / Book: 1.15
  • Annual Dividend: $0.05
  • Dividend Yield: 0.3%
  • EBIDTA: ($8,170,000.00)
  • Net Margins: -4.09%
  • Return on Equity: -8.18%
  • Return on Assets: -3.94%
  • Debt-to-Equity Ratio: 0.35%
  • Current Ratio: 1.85%
  • Quick Ratio: 1.24%
  • Average Volume: 288,271 shs.
  • Beta: 2.06
  • Short Ratio: 27.33

Frequently Asked Questions for Invacare (NYSE:IVC)

What is Invacare's stock symbol?

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

How often does Invacare pay dividends? What is the dividend yield for Invacare?

Invacare announced a quarterly dividend on Thursday, May 18th. Investors of record on Monday, July 3rd will be given a dividend of $0.0125 per share on Friday, July 14th. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend is Thursday, June 29th. View Invacare's Dividend History.

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) announced its earnings results on Monday, May, 8th. The company reported ($0.47) EPS for the quarter, topping analysts' consensus estimates of ($0.53) by $0.06. The business earned $231.70 million during the quarter, compared to the consensus estimate of $226.71 million. Invacare had a negative return on equity of 8.18% and a negative net margin of 4.09%. The firm's quarterly revenue was down 10.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.25) EPS. View Invacare's Earnings History.

Where is Invacare's stock going? Where will Invacare's stock price be in 2017?

2 brokerages have issued 12-month price objectives for Invacare's shares. Their forecasts range from $17.00 to $17.00. On average, they anticipate Invacare's share price to reach $17.00 in the next twelve months. View Analyst Ratings for Invacare.

Who are some of Invacare's key competitors?

Who owns Invacare stock?

Invacare's stock is owned by many different of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.72%), Dimensional Fund Advisors LP (8.24%), Brandes Investment Partners LP (6.23%), Heartland Advisors Inc. (5.30%), Hotchkis & Wiley Capital Management LLC (4.13%) and Royce & Associates LP (3.74%). Company insiders that own Invacare stock include Anthony Laplaca, Baiju R Shah, C Martin Harris, Clifford D Nastas, Dale C Laporte, Dean J Childers, Matthew E Monaghan, Michael F Delaney and Robert K Gudbranson. View Institutional Ownership Trends for Invacare.

Who sold Invacare stock? Who is selling Invacare stock?

Invacare's stock was sold by a variety of institutional investors in the last quarter, including Heartland Advisors Inc., Granahan Investment Management Inc. MA, Goldman Sachs Group Inc., Morgan Stanley, TIAA CREF Investment Management LLC, Hotchkis & Wiley Capital Management LLC, Netols Asset Management Inc. and Nationwide Fund Advisors. Company insiders that have sold Invacare stock in the last year include C Martin Harris and Dale C Laporte. View Insider Buying and Selling for Invacare.

Who bought Invacare stock? Who is buying Invacare stock?

Invacare's stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Boston Partners, Royce & Associates LP, Brandes Investment Partners LP, Dimensional Fund Advisors LP, MARSHALL WACE ASIA Ltd, Marshall Wace North America L.P. and Schwab Charles Investment Management Inc.. Company insiders that have bought Invacare stock in the last two years include Anthony Laplaca, Baiju R Shah, Clifford D Nastas, Dean J Childers, Matthew E Monaghan and Robert K Gudbranson. View Insider Buying and Selling for Invacare.

How do I buy Invacare stock?

Shares of Invacare can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Invacare stock cost?

One share of Invacare stock can currently be purchased for approximately $14.35.

Analyst Ratings

Consensus Ratings for Invacare (NYSE:IVC) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.00 (18.47% upside)

Analysts' Ratings History for Invacare (NYSE:IVC)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/28/2017StephensUpgradeEqual Weight -> OverweightHighView Rating Details
10/6/2016KeyCorpSet Price TargetBuy$17.00N/AView Rating Details
(Data available from 5/27/2015 forward)


Earnings History for Invacare (NYSE:IVC)
Earnings by Quarter for Invacare (NYSE:IVC)
Earnings History by Quarter for Invacare (NYSE:IVC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2017Q1 17($0.53)($0.47)$226.71 million$231.70 millionViewListenView Earnings Details
2/9/2017Q416($0.30)($0.46)$262.53 million$246.70 millionViewListenView Earnings Details
10/31/2016Q316($0.20)($0.37)$271.47 million$268.15 millionViewListenView Earnings Details
7/28/2016Q216($0.24)($0.33)$270.10 million$275.00 millionViewListenView Earnings Details
4/28/2016Q116($0.22)($0.25)$272.17 million$257.60 millionViewN/AView Earnings Details
2/11/2016Q415($0.16)($0.06)$284.83 million$283.26 millionViewListenView Earnings Details
10/22/2015Q315($0.22)($0.13)$286.63 million$283.80 millionViewListenView Earnings Details
7/23/2015Q215($0.20)($0.23)$296.07 million$286.30 millionViewListenView Earnings Details
4/23/2015Q115($0.29)($0.21)$275.85 million$289.00 millionViewN/AView Earnings Details
2/5/2015Q414($0.23)($0.12)$310.40 million$318.20 millionViewN/AView Earnings Details
10/23/2014Q314($0.26)($0.56)$331.60 million$320.50 millionViewN/AView Earnings Details
7/24/2014Q214($0.28)($0.36)$327.85 million$331.31 millionViewN/AView Earnings Details
4/24/2014Q114($0.22)($0.49)$326.90 million$309.10 millionViewN/AView Earnings Details
2/6/2014Q413($0.18)$0.19$336.20 million$334.99 millionViewN/AView Earnings Details
10/24/2013Q313($0.26)($0.18)$333.10 million$341.20 millionViewN/AView Earnings Details
7/25/2013Q2 2013($0.20)($0.27)$320.00 million$351.80 millionViewN/AView Earnings Details
4/25/2013Q1 2013($0.09)($0.36)$310.00 million$337.60 millionViewN/AView Earnings Details
2/8/2013Q4 2012$0.25$0.21$422.70 million$360.42 millionViewN/AView Earnings Details
10/25/2012$0.31$0.34ViewN/AView Earnings Details
7/26/2012$0.30$0.30ViewN/AView Earnings Details
2/2/2012$0.66$0.72ViewN/AView Earnings Details
7/28/2011$0.46$0.45ViewN/AView Earnings Details
4/28/2011$0.25$0.32ViewN/AView Earnings Details
2/3/2011$0.63$0.65ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Invacare (NYSE:IVC)
2017 EPS Consensus Estimate: ($1.33)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.53)($0.53)($0.53)
Q2 20171($0.39)($0.39)($0.39)
Q3 20171($0.24)($0.24)($0.24)
Q4 20171($0.17)($0.17)($0.17)
(Data provided by Zacks Investment Research)


Current Dividend Information for Invacare (NYSE:IVC)
Next Dividend:7/14/2017
Annual Dividend:$0.05
Dividend Yield:0.35%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:-3.79% (Trailing 12 Months of Earnings)
-4.17% (Based on This Year's Estimates)
-29.41% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Invacare (NYSE:IVC)

Dividend History by Quarter for Invacare (NYSE:IVC)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Invacare (NYSE:IVC)
Insider Ownership Percentage: 2.60%
Insider Trades by Quarter for Invacare (NYSE:IVC)
Institutional Ownership by Quarter for Invacare (NYSE:IVC)
Insider Trades by Quarter for Invacare (NYSE:IVC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/16/2017Dale C. LaporteDirectorSell2,737$14.95$40,918.15View SEC Filing  
11/16/2016Dale C. LaporteDirectorSell375$11.90$4,462.50View SEC Filing  
11/2/2016Baiju R. ShahDirectorBuy1,000$9.04$9,040.00View SEC Filing  
11/2/2016Matthew E MonaghanChairmanBuy11,000$9.00$99,000.00View SEC Filing  
8/4/2016C Martin HarrisDirectorSell475$11.49$5,457.75View SEC Filing  
5/17/2016Dale C LaporteDirectorSell375$10.33$3,873.75View SEC Filing  
5/16/2016Dean J ChildersSVPBuy10,000$10.40$104,000.00View SEC Filing  
5/6/2016Clifford D NastasDirectorBuy5,000$11.01$55,050.00View SEC Filing  
5/3/2016Matthew E MonaghanCEOBuy4,500$11.39$51,255.00View SEC Filing  
5/2/2016Anthony LaplacaVPBuy1,000$11.23$11,230.00View SEC Filing  
5/2/2016Baiju R ShahDirectorBuy2,000$11.27$22,540.00View SEC Filing  
2/29/2016Anthony LaplacaVPBuy1,000$12.38$12,380.00View SEC Filing  
2/29/2016Matthew E MonaghanCEOBuy8,000$12.31$98,480.00View SEC Filing  
2/29/2016Robert K GudbransonCFOBuy4,200$12.01$50,442.00View SEC Filing  
12/10/2015Michael F. DelaneyDirectorSell1,000$19.05$19,050.00View SEC Filing  
12/8/2014C Martin HarrisDirectorSell1,125$16.22$18,247.50View SEC Filing  
12/9/2013C Martin HarrisDirectorSell1,775$22.15$39,316.25View SEC Filing  
5/6/2013Joseph B Richey IISVPBuy1,000$13.74$13,740.00View SEC Filing  
5/1/2013Gerald B BlouchCEOBuy1,000$13.59$13,590.00View SEC Filing  
4/30/2013Aaron Malachi Mixon IIIChairmanBuy4,300$13.22$56,846.00View SEC Filing  
4/30/2013Louis F J SlangenSVPBuy1,000$13.05$13,050.00View SEC Filing  
4/29/2013Aaron Malachi Mixon IIIChairmanBuy45,700$12.53$572,621.00View SEC Filing  
4/29/2013Dale C LaporteDirectorBuy1,000$12.24$12,240.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Invacare (NYSE:IVC)
Latest Headlines for Invacare (NYSE:IVC)
DateHeadline logoInvacare to Present at Jefferies 2017 Global Healthcare Conference - May 26 at 2:34 AM logoInvacare Continues Realignment as Part of Its Ongoing Transformation - May 24 at 5:55 PM logoBravo Promotes Chris Yessayan to President - May 23 at 5:36 PM logoInvacare Co. (IVC) Director Sells $40,918.15 in Stock - May 18 at 8:33 PM logoInvacare Co. (IVC) Announces Quarterly Dividend of $0.01 - May 18 at 2:14 PM logoBalter Liquid Alternatives, LLC Buys Craft Brew Alliance Inc, Nuance Communications Inc, ... - May 13 at 5:37 PM logoETFs with exposure to Invacare Corp. : May 11, 2017 - May 11 at 8:19 PM logoKeyCorp Analysts Reduce Earnings Estimates for Invacare Co. (IVC) - May 11 at 8:32 AM logoEdited Transcript of IVC earnings conference call or presentation 9-May-17 12:30pm GMT - May 10 at 11:22 PM logoInvacare Corp. :IVC-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 - May 10 at 1:12 PM logoInvacare Corporation's (IVC) CEO Matt Monaghan on Q1 2017 Results - Earnings Call Transcript - May 9 at 5:48 PM logoInvacare Co. (IVC) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS - May 9 at 12:17 AM logoInvacare Co. (IVC) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS - May 8 at 11:53 PM logoInvacare reports 1Q loss - May 8 at 6:22 PM logoBRIEF-Invacare Q1 GAAP loss per share $0.52 - May 8 at 5:40 PM logoInvacare Reports Results for the First Quarter 2017 - May 8 at 5:40 PM logoInvacare misses by $0.08 - May 8 at 5:17 PM logoInvacare Introduces ‘Outcomes by Design’ Program for Post-Acute Care Facilities - May 3 at 10:26 PM logoInvacare (IVC) Earning Somewhat Positive Press Coverage, Analysis Finds - April 29 at 10:47 PM logoWhy Invacare Corporation's Shares Rallied 12.1% Today - April 28 at 6:58 PM logoWhy Invacare Corporation's Shares Rallied 12.1% Today - April 28 at 6:58 PM logoInvacare Co. (IVC) Upgraded by Stephens to Overweight - April 28 at 8:01 AM logoBRIEF-Invacare says completed 2 milestones required to initiate FDA's re-inspection - April 27 at 6:36 PM logoInvacare Reports Completion of Consent Decree Milestones - April 27 at 6:36 PM logoVery Favorable News Coverage Very Likely to Affect Invacare (IVC) Share Price - April 25 at 9:15 AM logoNegative Pressure Wound Therapy (NPWT) Market 12 Companies Product Pipeline Developments Published in 2017 Report at ReportsnReports - April 20 at 11:06 PM logoSomewhat Favorable News Coverage Extremely Likely to Impact Invacare (IVC) Share Price - April 20 at 11:09 AM logoInvacare Corp. – Value Analysis (NYSE:IVC) : April 19, 2017 - April 19 at 5:53 PM logoPortable Oxygen Concentrators Market: North America Estimated to Account for ... - April 18 at 5:29 PM logoInvacare Corp. breached its 50 day moving average in a Bullish Manner : IVC-US : April 18, 2017 - April 18 at 10:58 AM logoZacks: Invacare Co. (IVC) Given Consensus Recommendation of "Strong Buy" by Brokerages - April 17 at 10:34 PM logoInvacare (IVC) Earning Favorable News Coverage, Analysis Finds - April 17 at 8:21 PM logoFavorable Media Coverage Very Likely to Impact Invacare (IVC) Share Price - April 14 at 10:49 PM logoBRIEF-Invacare says received notification from FDA that it accepted recent second certification report - April 14 at 5:56 PM logoInvacare Corporation to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results - April 13 at 9:27 AM logoInvacare Co. (IVC) Upgraded to "Hold" by Zacks Investment Research - April 12 at 12:50 AM logoInvacare Co. (IVC) Coverage Initiated at Stephens - April 4 at 6:00 PM logoThe Rehab Equipment Market Will Reach USD 14.91 Billion by 2021 - March 31 at 6:01 PM logoInvacare Corporation (IVC) Ex-Dividend Date Scheduled for March 30, 2017 - Nasdaq - March 31 at 7:50 AM logoZacks: Invacare Co. (IVC) Receives Consensus Rating of "" from Analysts - March 30 at 12:14 PM logoPressure Relief Devices Market Size & Forecast By Type (Low-Tech Devices , High-Tech Devices ), And Trend Analysis From 2014 - 2025 - March 28 at 11:03 AM logoAnnual Needham Healthcare Conference - Business Wire (press release) - March 26 at 9:13 AM logoInvacare Corporation to Present at 16th Annual Needham Healthcare Conference - March 24 at 9:32 AM logoINVACARE CORP Financials - March 16 at 6:49 PM logoPressure Relief Devices Market Size to Reach $4.1 Billion by 2025: Grand View Research, Inc. - March 14 at 10:13 PM logoINVACARE CORP Files SEC form 10-K, Annual Report - March 10 at 7:11 PM logoInvacare Declares Quarterly Dividend - February 22 at 12:33 PM logoEARNINGS SUMMARY: Details of Invacare Corp Q4 Earnings Report - February 9 at 11:58 PM logoInvacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December … - February 9 at 11:58 PM logoInvacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2016 - February 9 at 11:58 PM



Invacare (IVC) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by Staff